Lower riskDrug recall · FDA · Published February 4, 2026
Somerset Therapeutics Dexamethasone Injection Recall: Impurities May Cause Harm
Somerset Therapeutics recalls 10x10mL Dexamethasone Sodium Phosphate injection vials due to impurities detected during stability testing. These impurities could pose health risks if used beyond expiry.
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Take action
Contact the company
📍Recalling firmSOMERSET THERAPEUTICS LLC300 Franklin Square Dr · Somerset, NJ 08873-4187
“Somerset Therapeutics Dexamethasone Injection Recall: Impurities May Cause Harm.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31492-somerset-therapeutics-dexamethasone-injection-recall-impurities-may-cause-harm. Based on FDA recall #D-0398-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0398-2026%22&limit=1).
The FDA announced on Feb. 4, 2026, that Somerset Therapeutics is recalling Dexamethasone Sodium Phosphate Injection due to failed impurity specifications. The recall affects 62,190 vials distributed nationwide.
The product contains out-of-specification impurities, specifically Dexamethasone Sodium Phosphate EP impurity G and dexamethasone formate, which were observed during long-term stability testing at the 24-month expiry. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Somerset Therapeutics has issued four other recalls since June 4, 2020, including a Nov. 26, 2025, recall for subpotent Cisatracurium Besylate Injection and a Dec. 16, 2024, recall for Atropine Sulfate Ophthalmic Solution. Other recent recalls of similar products include Sun Pharmaceutical's Dec. 30, 2025, Fluocinolone Acetonide Solution recall for impurity risk and Sagent's May 4, 2026, Busulfan Injection recall for failed impurities.
How to tell if you have this one
Check for the product name 'Dexamethasone Sodium Phosphate Injection, USP, 100 mg/10 mL (10 mg/mL), 10x10 mL Multiple Dose Vials' with NDC carton number 70069-025-10 and vial number 70069-025-01. The lot number is A240421 with an expiration date of 07/31/2026.
Brand
Somerset Therapeutics
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the NDC carton number 70069-025-10 and vial number 70069-025-01 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 49 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0398-2026 (February 4, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0398-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.